Cargando…
Influence of trial design, heterogeneity and regulatory environment on the results of clinical trials: An appraisal in the context of recent trials on acute stroke intervention
The outcome of randomized controlled trials can vary depending on the eligibility criteria of the patients entering into the trial, as well as the heterogeneity of the eligible population and/or the interventions. If the subject population and/or interventions are heterogeneous, the final outcome of...
Autores principales: | Srijithesh, P. R., Husain, Shakir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251006/ https://www.ncbi.nlm.nih.gov/pubmed/25506154 http://dx.doi.org/10.4103/0972-2327.143984 |
Ejemplares similares
-
Homogeneity and the outcome of clinical trials: An appraisal of the outcome of recent clinical trials on endovascular intervention in acute ischemic stroke
por: Husain, Shakir, et al.
Publicado: (2016) -
Border Zones of Evidence: How Non-evidence Based Factors Influence Evidence Generation and Clinical Practice in Stroke Medicine
por: Srijithesh, PR, et al.
Publicado: (2020) -
Design Considerations for Clinical Trials in Aphasia
por: Palmer, Rebecca
Publicado: (2020) -
Placebo control group in COVID-19 vaccine trials: context and timing matters
por: Dal-Ré, Rafael
Publicado: (2021) -
Digital Therapeutics for MCI and Alzheimer’s disease: A Regulatory Perspective — Highlights From The Clinical Trials on Alzheimer’s Disease conference (CTAD)
por: Shuren, J., et al.
Publicado: (2022)